A network pharmacology approach to understanding the mechanisms of action of traditional medicine: Bushenhuoxue formula for treatment of chronic kidney disease

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Shi, Shao Hua ^a   Cai, Yue Piao ^a   Cai, Xiao Jun ^a   Zheng, Xiao Yong ^a   Cao, Dong Sheng ^b   Ye, Fa Qing ^a   Xiang, Zheng ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALYCOSIN; CHINESE DRUG; CREATININE; CURCUMIN; CYTOKINE; INFLAMMATORY FACTOR; NATURAL PRODUCT; NITROGEN; QUERCETIN; RHEIN; TANSHINONE IIA; UNCLASSIFIED DRUG; UREA; BUSHEN HUOXUE; HERBACEOUS AGENT;

ARTICLE; BIOINFORMATICS; BLOOD CLOTTING; CELL METABOLISM; CHEMICAL COMPOSITION; CHEMICAL STRUCTURE; CHEMOINFORMATICS; CHINESE MEDICINE; CHRONIC KIDNEY DISEASE; COMPOUND TARGET NETWORK; COMPUTER ANALYSIS; CREATININE BLOOD LEVEL; DATA MINING; DISEASE ASSOCIATION; DNA SCREENING; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; DRUG POTENTIATION; DRUG TARGETING; EXTRACELLULAR MATRIX; FIBRINOLYSIS; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC TRANSDUCTION; HOMEOSTASIS; HUMAN; MAIN COMPONENT TARGET NETWORK; MOLECULAR DOCKING; NATURAL PRODUCT TARGET NETWORK; NETWORK BIOLOGY; NONHUMAN; PHARMACOLOGICAL PROCEDURES; PHYTOCHEMISTRY; PROCESS DEVELOPMENT; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PROTEIN INTERACTION; RELIABILITY; UREA NITROGEN BLOOD LEVEL; URETER OBSTRUCTION; BIOLOGY; CHEMISTRY; RENAL INSUFFICIENCY, CHRONIC;

COMPUTATIONAL BIOLOGY; DRUGS, CHINESE HERBAL; HUMANS; MEDICINE, CHINESE TRADITIONAL; MOLECULAR DOCKING SIMULATION; PROTEIN INTERACTION MAPS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84897132986     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089123     Document Type: Article

References (165)

1. Stone R (2008) Biochemistry. Lifting the veil on traditional Chinese medicine. Science 319: 709-710.
2. Tapmeier TT, Brown KL, Tang Z, Sacks SH, Sheerin NS, et al. (2008) Reimplantation of the ureter after unilateral ureteral obstruction provides a model that allows functional evaluation. Kidney Int 73: 885-889. (Pubitemid 351398288)
3. Wang YJ, He LQ, Sun W, Lu Y, Wang XQ, et al. (2012) Optimized project of traditional Chinese medicine in treating chronic kidney disease stage 3: A multicenter double-blinded randomized controlled trial. Journal of Ethnopharmacology 139: 757-764.
4. Luyckx VA (2012) Nephrotoxicity of Alternative Medicine Practice. Advances in Chronic Kidney Disease 19: 129-141.
5. Jha V (2010) Herbal medicines and chronic kidney disease. Nephrology 15: 10-17.
6. Li XM, Wang HY (2005) Chinese herbal medicine in the treatment of chronic kidney disease. Advances in Chronic Kidney Disease 12: 276-281.
7. Nagler EV, Webster AC, Vanholder R, Zoccali C (2012) Antidepressants for depression in stage 3-5 chronic kidney disease: a systematic review of pharmacokinetics, efficacy and safety with recommendations by European Renal Best Practice (ERBP). Nephrology Dialysis Transplantation 27: 3736-3745.
8. Kim W, Moon SO, Lee SY, Jang KY, Cho CH, et al. (2006) COMP-angiopoietin-1 ameliorates renal fibrosis in a unilateral ureteral obstruction model. J Am Soc Nephrol 17: 2474-2483. (Pubitemid 44300963)
9. Navaneethan SD, Aloudat S, Singh S (2008) A systematic review of patient and health system characteristics associated with late referral in chronic kidney disease. Bmc Nephrology 9.
10. Chen XM, Li DY, Hu Y, Jin MW, Zhou LP, et al. (2011) Simultaneous determination of 3,3′, 4′, 5,7-pentamethylquercetin and its possible metabolite 3,3′, 4′, 7-tetramethylquercetin in dog plasma by liquid chromatography-tandem mass spectrometry and its application to preclinical pharmacokinetic study. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences 879: 2339-2344.
11. Alasbahi RH, Melzig MF (2012) Forskolin and derivatives as tools for studying the role of cAMP. Pharmazie 67: 5-13.
12. Chen XH, Zhao YG, Shen HY, Jin MC (2012) Application of dispersive solid-phase extraction and ultra-fast liquid chromatography-tandem quadrupole mass spectrometry in food additive residue analysis of red wine. Journal of Chromatography A 1263: 34-42.
13. Akgul T, Huri E, Yagmurdur H, Ayyildiz A, Ustun H, et al. (2011) Phosphodiesterase 5 inhibitors attenuate renal tubular apoptosis after partial unilateral ureteral obstruction: An experimental study. Kaohsiung Journal of Medical Sciences 27: 15-19.
14. Abbasian N, Herbert K, Bevington A, Brunskill N, Burton J (2012) Hyperphosphataemia and Microvesicle Formation: A Novel Mechanism for Cardiovascular Risk in Chronic Kidney Disease. Nephrology Dialysis Transplantation 27: 241-241.
15. Cho DY, Kim YA, Przytycka TM (2012) Chapter 5: Network Biology Approach to Complex Diseases. Plos Computational Biology 8.
16. Morphy R, Rankovic Z (2007) Fragments, network biology and designing multiple ligands. Drug Discovery Today 12: 156-160. (Pubitemid 46176667)
17. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, et al. (2007) Prevalence of chronic kidney disease in the United States. Jama-Journal of the American Medical Association 298: 2038-2047. (Pubitemid 350074801)
18. Zhang LX, Wang F, Wang L, Wang WK, Liu BC, et al. (2012) Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 379: 815-822.
19. Li SG, Zhang YQ (2009) Characterization and renal protective effect of a polysaccharide from Astragalus membranaceus. Carbohydrate Polymers 78: 343-348.
20. Huang LM, Liang H (2006) Effects of Astragali radix on renal function and its protein expression of IgA nephropathy in mice. Acta Pharmacologica Sinica 27: 321-322.
21. Sheng BW, Chen XF, Zhao J, He DL, Nan XY (2005) Astragalus membranaceus reduces free radical-mediated injury to renal tubules in rabbits receiving high-energy shock waves. Chinese Medical Journal 118: 43-49. (Pubitemid 40124964)
22. Jariyawat S, Kigpituck P, Suksen K, Chuncharunee A, Chaovanalikit A, et al. (2009) Protection against cisplatin-induced nephrotoxicity in mice by Curcuma comosa Roxb. ethanol extract. Journal of Natural Medicines 63: 430-436.
23. Khorsandi L, Orazizadeh M (2008) Protective effect of Curcuma longa extract on acetaminophen induced nephrotoxicity in mice. Daru-Journal of Faculty of Pharmacy 16: 155-159.
24. Hong JY, Sato EE, Kira Y, Nishikawa M, Shimada K, et al. (2006) Curcuma Aromatica inhibits diabetic nephropathy in the rat. Journal of Food Science 71: S626-S632. (Pubitemid 44898839)
25. Wang H, Song HX, Yue JR, Li J, Hou YB, et al. (2012) Rheum officinale (a traditional Chinese medicine) for chronic kidney disease. Cochrane Database of Systematic Reviews.
26. Zhang G, ElNahas AM (1996) The effect of rhubarb extract on experimental renal fibrosis. Nephrology Dialysis Transplantation 11: 186-190. (Pubitemid 26038487)
27. Li LS (1996) Rhubarb in preventing progression of chronic renal disease. Nephrology 2: S146-S150.
28. Zhang JH, Li LS (1992) The Long-Term Effects of Rhubarb on Preventing Progression of Chronic-Renal-Failure (Crf). Kidney International 42: 498-498.
29. Biggar PH, Liangos O, Fey H, Brandenburg VM, Ketteler M (2011) Vitamin D, chronic kidney disease and survival: a pluripotent hormone or just another bone drug? Pediatric Nephrology 26: 7-18.
30. Chung HY, Yokozawa T, Oura H (1988) Acute Effect of Extract from Salviae Miltiorrhizae Radix on Renal-Function in Renal-Failure Rats. Chemical &Pharmaceutical Bulletin 36: 274-278. (Pubitemid 18073391)
31. Li YG, Song L, Liu M, Zhi-Bi-Hu, Wang ZT (2009) Advancement in analysis of Salviae miltiorrhizae Radix et Rhizoma (Danshen). Journal of Chromatography A 1216: 1941-1953.
32. Kang DG, Yun YG, Ryoo JH, Lee HS (2002) Anti-hypertensive effect of water extract of Danshen on renovascular hypertension through inhibition of the renin angiotensin system. American Journal of Chinese Medicine 30: 87-93. (Pubitemid 41758924)
33. Guan XH, Dei-Anane G, Bruns H, Chen J, Nickkholgh A, et al. (2009) Danshen protects kidney grafts from ischemia/reperfusion injury after experimental transplantation. Transplant International 22: 232-241.
34. Xiao-hong D, Jing-cheng D, Li-qun H (2011) Effects of Bushen Huoxue Recipe on Urinary Levels of Albumin,IL-6,TGF- b-1 and MCP-1 in Chronic Nephritis Patients of Shen-deficiency Blood-stasis Syndrome. Chinese Journal of Integrated Traditional and Western Medicine 31 765-768.
35. Zhi-qing G, Hao-peng K, Jun Z, Lin-qi1 Z (2010) Influence of BushenHuoxuefang on the Expression of Platelet Derived Growth Factor BB in Renal Interstitial Fibrosis Rats. China Journal of Traditional Chinese Medicine and Pharmacy 25 296-298.
36. Hamosh A, Scott AF, Amberger JS, Bocchini CA, McKusick VA (2005) Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Research 33: D514-D517. (Pubitemid 40207927)
37. Becker KG, Barnes KC, Bright TJ, Wang SA (2004) The Genetic Association Database. Nature Genetics 36: 431-432.
38. Edgar R, Domrachev M, Lash AE (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Research 30: 207-210. (Pubitemid 34679544)
39. Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proceedings of the National Academy of Sciences of the United States of America 98: 5116-5121. (Pubitemid 32397092)
40. Li M, Sun XH, Zhou ZH, Yu Z, Jin SG, et al. (2013) Beneficial therapeutic effect of Chinese herbal Bushen formula on CHB patients with mildly elevated alanine aminotransferase by down-regulating CD4+CD25+T cells. Journal of Ethnopharmacology 146: 614-622.
41. Knox C, Law V, Jewison T, Liu P, Ly S, et al. (2011) DrugBank 3.0: a comprehensive resource for 'Omics' research on drugs. Nucleic Acids Research 39: D1035-D1041.
42. Yongzheng H (2011) Comprehensive natural products in traditional Chinese medicine. Shanghai: Shanghai scientific & Technical Publishers.
43. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews 23: 3-25. (Pubitemid 27046991)
44. Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, et al. (2008) DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res 36: D901-906. (Pubitemid 351149842)
45. Berman H, Henrick K, Nakamura H, Markley JL (2007) The worldwide Protein Data Bank (wwPDB): ensuring a single, uniform archive of PDB data. Nucleic Acids Res 35: D301-303. (Pubitemid 46056219)
46. Trott O, Olson AJ (2010) Software News and Update AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading. Journal of Computational Chemistry 31: 455-461.
47. Li BH, Xu X, Wang X, Yu H, Li XX, et al. (2012) A Systems Biology Approach to Understanding the Mechanisms of Action of Chinese Herbs for Treatment of Cardiovascular Disease. International Journal of Molecular Sciences 13: 13501-13520.
48. Greenbaum D, Colangelo C, Williams K, Gerstein M (2003) Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biology 4.
49. Griffin TJ, Gygi SP, Ideker T, Rist B, Eng J, et al. (2002) Complementary profiling of gene expression at the transcriptome and proteome levels in Saccharomyces cerevisiae. Molecular & Cellular Proteomics 1: 323-333.
50. Martin A, Ochagavia ME, Rabasa LC, Miranda J, Fernandez-de-Cossio J, et al. (2010) BisoGenet: a new tool for gene network building, visualization and analysis. Bmc Bioinformatics 11.
51. Barabasi AL, Oltvai ZN (2004) Network biology: Understanding the cell's functional organization. Nat Rev Genet 5: 101-U115.
52. Wang JX, Li M, Wang H, Pan Y (2012) Identification of Essential Proteins Based on Edge Clustering Coefficient. Ieee-Acm Transactions on Computational Biology and Bioinformatics 9: 1070-1080.
53. Zhang P, Wang JL, Li XJ, Li MH, Di ZR, et al. (2008) Clustering coefficient and community structure of bipartite networks. Physica a-Statistical Mechanics and Its Applications 387: 6869-6875.
54. Brandes U (2001) A faster algorithm for betweenness centrality. Journal of Mathematical Sociology 25: 163-177.
55. Hwang WC, Zhang A, Ramanathan M (2008) Identification of Information Flow-Modulating Drug Targets: A Novel Bridging Paradigm for Drug Discovery. Clinical Pharmacology & Therapeutics 84: 563-572.
56. Chea E, Livesay DR (2007) How accurate and statistically robust are catalytic site predictions based on closeness centrality? Bmc Bioinformatics 8.
57. Draghici S, Khatri P, Tarca AL, Amin K, Done A, et al. (2007) A systems biology approach for pathway level analysis. Genome Research 17: 1537-1545. (Pubitemid 47529438)
58. Chevalier RL, Thornhill BA, Wolstenholme JT, Kim A (1999) Unilateral ureteral obstruction in early development alters renal growth: dependence on the duration of obstruction. J Urol 161: 309-313. (Pubitemid 29422353)
59. Nagao S, Nishii K, Yoshihara D, Kurahashi H, Nagaoka K, et al. (2008) Calcium channel inhibition accelerates polycystic kidney disease progression in the Cy/+ rat. Kidney International 73: 269-277.
60. Choi ME, Ding Y, Il Kim S (2012) TGF-beta Signaling via TAK1 Pathway: Role in Kidney Fibrosis. Seminars in Nephrology 32: 244-252.
61. Skupien J, Poznik GD, Smiles AM, Kure M, Pezzolesi MG, et al. (2009) TGF beta Signaling Pathway in Diabetic Kidney Disease. Evidence for Association of BMPR1B Gene Polymorphisms with Diabetic Nephropathy in GoKinD Collection. Diabetes 58: A219-A219.
62. Chuang PY, He JC (2010) JAK/STAT signaling in renal diseases. Kidney International 78: 231-234.
63. Tang SCW, Leung JCK, Chan LYY, Tsang AWL, Lai KN (2006) Activation of tubular epithelial cells in diabetic nephropathy and the role of the peroxisome proliferator-activated receptor-gamma agonist. Journal of the American Society of Nephrology 17: 1633-1643. (Pubitemid 43794666)
64. Letavernier E, Perez J, Joye E, Bellocq A, Fouqueray B, et al. (2005) Peroxisome proliferator-activated receptor beta/delta exerts a strong protection from ischemic acute renal failure. Journal of the American Society of Nephrology 16: 2395-2402. (Pubitemid 41725057)
65. Zhang Q, Xiao XH, Li M, Li WH, Yu M, et al. (2012) Gene expression profiling in glomeruli of diabetic nephropathy rat. Experimental Biology and Medicine 237: 903-911.
66. Siragy HM, Carey RM (2010) Role of the Intrarenal Renin-Angiotensin- Aldosterone System in Chronic Kidney Disease. American Journal of Nephrology 31: 541-550.
67. Palya A, Noor F, Fleszler F, Shahabdeen S, David R, et al. (2008) Role of renin angiotensin system (RAS) in anemia related to chronic kidney disease (CKD). American Journal of Kidney Diseases 51: A77-A77.
68. Remuzzi G, Perico N, Macia M, Ruggenenti P (2005) The role of renin-angiotensin- aldosterone system in the progression of chronic kidney disease. Kidney International 68: 57-65.
69. Liu F, Lou YL, Wu J, Ruan QF, Xie A, et al. (2012) Upregulation of MicroRNA-210 Regulates Renal Angiogenesis Mediated by Activation of VEGF Signaling Pathway under Ischemia/Perfusion Injury in vivo and in vitro. Kidney & Blood Pressure Research 35: 182-191.
70. Lin SL, Chang FC, Schrimpf C, Chen YT, Wu CF, et al. (2011) Targeting Endothelium-Pericyte Cross Talk by Inhibiting VEGF Receptor Signaling Attenuates Kidney Microvascular Rarefaction and Fibrosis. American Journal of Pathology 178: 911-923.
71. Qin Y, Alderliesten MC, Stokman G, Pennekamp P, Bonventre JV, et al. (2011) Focal Adhesion Kinase Signaling Mediates Acute Renal Injury Induced by Ischemia/Reperfusion. American Journal of Pathology 179: 2766-2778.
72. Matsuura S, Kondo S, Suga K, Kinoshita Y, Urushihara M, et al. (2011) Expression of Focal Adhesion Proteins in the Developing Rat Kidney. Journal of Histochemistry & Cytochemistry 59: 864-874.
73. Li FM, Jones JE, Villar VA, Armando I, Yu PY, et al. (2010) Dopamine 1 Receptor Down-Regulation Impairs the Insulin Signaling Pathway in Human Renal Proximal Tubule Cells. Hypertension 56: E123-E123.
74. Bailey JL, Price SR, Mitch WE (2002) Insulin resistance in chronic renal failure (CRF) is associated with changes in the phosphatidylinositol 3-kinase (PI3K) insulin signaling pathway in muscle. Journal of the American Society of Nephrology 13: 522a-522a.
75. Lv ZM, Wang Q, Wan Q, Lin JG, Hu MS, et al. (2011) The Role of the p38 MAPK Signaling Pathway in High Glucose-Induced Epithelial-Mesenchymal Transition of Cultured Human Renal Tubular Epithelial Cells. Plos One 6.
76. Li JH, Huang XR, Cooper M, Zhou HJ, Oldfield M, et al. (2002) AGEs induce renal tubular epithelial-myofibroblast transdifferentiation via the MAPK-Smad signaling cross-talk pathway in vitro. Journal of the American Society of Nephrology 13: 287a-287a.
77. Wasserman RL (2012) Progress in Gammaglobulin Therapy for Immunodeficiency: From Subcutaneous to Intravenous Infusions and Back Again. Journal of Clinical Immunology 32: 1153-1164.
78. Gold MR, Ingham RJ, McLeod SJ, Christian SL, Scheid MP, et al. (2000) Targets of B-cell antigen receptor signaling: the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase-3 signaling pathway and the Rap 1 GTPase. Immunological Reviews 176: 47-68.
79. Jia J, Zhu F, Ma XH, Cao ZWW, Li YXX, et al. (2009) Mechanisms of drug combinations: interaction and network perspectives. Nature Reviews Drug Discovery 8: 111-128.
80. Keiser MJ, Setola V, Irwin JJ, Laggner C, Abbas AI, et al. (2009) Predicting new molecular targets for known drugs. Nature 462: 175-U148.
81. Zhu M, Gao L, Li X, Liu ZC, Xu C, et al. (2009) The analysis of the drug-targets based on the topological properties in the human protein-protein interaction network. Journal of Drug Targeting 17: 524-532.
82. Khan SS, Thomas G, Navaneethan SD (2012) Metabolic Syndrome and Progression of Chronic Kidney Disease: A Systematic Review. American Journal of Kidney Diseases 59: A47-A47.
83. Coca SG, Singanamala S, Parikh CR (2012) Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney International 81: 442-448.
84. Hwang W, Cho YR, Zhang AD, Ramanathan M (2006) A novel functional module detection algorithm for protein-protein interaction networks. Algorithms for Molecular Biology 1.
85. Joy MP, Brock A, Ingber DE, Huang S (2005) High-betweenness proteins in the yeast protein interaction network. Journal of Biomedicine and Biotechnology: 96-103. (Pubitemid 41627865)
86. Berger SI, Iyengar R (2009) Network analyses in systems pharmacology. Bioinformatics 25: 2466-2472.
87. Lee S, Park K, Kim D (2009) Building a drug-target network and its applications. Expert Opinion on Drug Discovery 4: 1177-1189.
88. Azuaje FJ, Zhang L, Devaux Y, Wagner DR (2011) Drug-target network in myocardial infarction reveals multiple side effects of unrelated drugs. Scientific Reports 1.
89. Tang JH, Zhan CY, Zhou JH (2008) Effects of Tanshinone II A on Transforming Growth Factor beta 1-Smads Signal Pathway in Renal Interstitial Fibroblasts of Rats. Journal of Huazhong University of Science and Technology-Medical Sciences 28: 539-542.
90. He DY, Lee L, Yang JW, Wang XY (2011) Preventive Effects and Mechanisms of Rhein on Renal Interstitial Fibrosis in Obstructive Nephropathy. Biological & Pharmaceutical Bulletin 34: 1219-1226.
91. Zhong F, Chen H, Han L, Jin YM, Wang WM (2011) Curcumin Attenuates Lipopolysaccharide-Induced Renal Inflammation. Biological & Pharmaceutical Bulletin 34: 226-232.
92. Gaedeke J, Noble NA, Border WA (2004) Curcumin blocks multiple sites of the TGF-beta signaling cascade in renal cells. Kidney International 66: 112-120. (Pubitemid 38870087)
93. Iqbal M, Okazaki Y, Okada S (2009) Curcumin attenuates oxidative damage in animals treated with a renal carcinogen, ferric nitrilotriacetate (Fe-NTA): implications for cancer prevention. Molecular and Cellular Biochemistry 324: 157-164.
94. Tang JY, Li S, Li ZH, Zhang ZJ, Hu GA, et al. (2010) Calycosin Promotes Angiogenesis Involving Estrogen Receptor and Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway in Zebrafish and HUVEC. Plos One 5.
95. Nabavi SM, Nabavi SF, Habtemariam S, Moghaddam AH, Latifi AM (2012) Ameliorative Effects of Quercetin on Sodium Fluoride-Induced Oxidative Stress in Rat's Kidney. Renal Failure 34: 901-906.
96. Jin RF, Bao HZ (2011) A DFT Study on the Radical Scavenging Activity of Hydroxyanthraquinone Derivatives in Rhubarb. International Journal of Quantum Chemistry 111: 1064-1071.
97. Ozturk M, Aydogmus-Ozturk F, Duru ME, Topcu G (2007) Antioxidant activity of stem and root extracts of Rhubarb (Rheum ribes): An edible medicinal plant. Food Chemistry 103: 623-630. (Pubitemid 46241717)
98. Zuo C, Xie XS, Qiu HY, Deng Y, Zhu D, et al. (2009) Astragalus mongholicus ameliorates renal fibrosis by modulating HGF and TGF-beta in rats with unilateral ureteral obstruction. Journal of Zhejiang University-Science B 10: 380-390.
99. Li JX, Xue B, Chai Q, Liu ZX, Zhao AP, et al. (2005) Antihypertensive effect of total flavonoid fraction of Astragalus complanatus in hypertensive rats. Chinese Journal of Physiology 48: 101-106. (Pubitemid 40867528)
100. Pan HJ, Sun HX, Pan YJ (2005) Adjuvant effect of ethanol extract of Semen Cuscutae on the immune responses to ovalbumin in mice. Journal of Ethnopharmacology 99: 99-103.
101. Yang JX, Wang YL, Bao Y, Guo J (2008) The total flavones from Semen cuscutae reverse the reduction of testosterone level and the expression of androgen receptor gene in kidney-yang deficient mice. Journal of Ethnopharmacology 119: 166-171.
102. Pei LX, Bao YW, Liu S, Zheng J, Chen XP (2013) Material Basis of Chinese Herbal Formulas Explored by Combining Pharmacokinetics with Network Pharmacology. Plos One 8.
103. ping CX, li XK, tao WY (2010) Systematic pharmacological evaluation of material basis for efficacy of Chinese herbal formula. Chin Trad Herbal Drugs 41: 1-5.
104. Wang SP, Liu L, Wang LL, Jiang P, Zhang JQ, et al. (2010) Screening and analysis of the multiple absorbed bioactive components and metabolites in rat plasma after oral administration of Jitai tablets by high-performance liquid chromatography/diode-array detection coupled with electrospray ionization tandem mass spectrometry. Rapid Communications in Mass Spectrometry 24: 1641-1652.
105. Cao J, Wei YJ, Qi LW, Li P, Qian ZM, et al. (2008) Determination of fifteen bioactive components in Radix et Rhizoma Salviae Miltiorrhizae by highperformance liquid chromatography with ultraviolet and mass spectrometric detection. Biomedical Chromatography 22: 164-172. (Pubitemid 351260194)
106. Liu Y, Li XR, Li YH, Wang LJ, Xue M (2010) Simultaneous determination of danshensu, rosmarinic acid, cryptotanshinone, tanshinone IIA, tanshinone I and dihydrotanshinone I by liquid chromatographic-mass spectrometry and the application to pharmacokinetics in rats. Journal of Pharmaceutical and Biomedical Analysis 53: 698-704.
107. Agarwal SK, Singh SS, Lakshmi V, Verma S, Kumar S (2001) Chemistry and pharmacology of rhubarb (Rheum species) - A review. Journal of Scientific &Industrial Research 60: 1-9. (Pubitemid 33645359)
108. Zhang HX, Liu MC (2004) Separation procedures for the pharmacologically active components of rhubarb. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences 812: 175-181.
109. Koyama J, Morita I, Kobayashi N (2007) Simultaneous determination of anthraquinones in rhubarb by high-performance liquid chromatography and capillary electrophoresis. Journal of Chromatography A 1145: 183-189.
110. Qi LW, Li P, Ren MT, Yu QT, Wen XD, et al. (2009) Application of highperformance liquid chromatography-electrospray ionization time-of-flight mass spectrometry for analysis and quality control of Radix Astragali and its preparations. Journal of Chromatography A 1216: 2087-2097.
111. Xiao HB, Krucker M, Albert K, Liang XM (2004) Determination and identification of isoflavonoids in Radix astragali by matrix solid-phase dispersion extraction and high-performance liquid chromatography with photodiode array and mass spectrometric detection. Journal of Chromatography A 1032: 117-124. (Pubitemid 38270351)
112. Wang D, Song Y, Li SL, Bian YY, Guan J, et al. (2006) Simultaneous analysis of seven astragalosides in Radix Astragali and related preparations by liquid chromatography coupled with electrospray ionization time-of-flight mass spectrometry. Journal of Separation Science 29: 2012-2022. (Pubitemid 44355483)
113. Zhang X, Sun YG, Cheng MC, Wang YQ, Xiao HB, et al. (2007) Simultaneous quantification of three isoflavonoid glycosies in rabbit plasma after oral administration of Astraogalus mongholicus extract by highperformance liquid chromatography coupled with electrospray ionization tandem mass spectrometry. Analytica Chimica Acta 602: 252-258. (Pubitemid 47539357)
114. Ye M, Yan YN, Guo DA (2005) Characterization of phenolic compounds in the Chinese herbal drug Tu-Si-Zi by liquid chromatography coupled to electrospray ionization mass spectrometry. Rapid Communications in Mass Spectrometry 19: 1469-1484. (Pubitemid 40801989)
115. Xiang Z, Wang XQ, Cai XJ, Zeng S (2011) Metabolomics Study on Quality Control and Discrimination of Three Curcuma Species based on Gas Chromatograph-Mass Spectrometry. Phytochemical Analysis 22: 411-418.
116. Lee KJ, Pomeroy K, Pramanick S, Borris RP (2012) Quantitative Analysis of Curcumin and Related Compounds in Curcuma Longa by Hplc and Lc-Ms. Pharmaceutical Biology 50: 591-591.
117. Yang KY, Lin LC, Tseng TY, Wang SC, Tsai TH (2007) Oral bioavailabilit of curcurnin in rat and the herbal analysis from Curcuma longa by LC-MS/MS. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences 853: 183-189.
118. Li R, Xiang C, Ye M, Li HF, Zhang X, et al. (2011) Qualitative and quantitative analysis of curcuminoids in herbal medicines derived from Curcuma species. Food Chemistry 126: 1890-1895.
119. Wichitnithad W, Jongaroonngamsang N, Pummangura S, Rojsitthisak P (2009) A Simple Isocratic HPLC Method for the Simultaneous Determination of Curcuminoids in Commercial Turmeric Extracts. Phytochemical Analysis 20: 314-319.
120. Yang FQ, Wang YT, Li SP (2006) Simultaneous determination of 11 characteristic components in three species of Curcuma rhizomes using pressurized liquid extraction and high-performance liquid chromatography. Journal of Chromatography A 1134: 226-231. (Pubitemid 44633953)
121. Yon JM, Baek IJ, Lee BJ, Yun YW, Nam SY (2011) Emodin and [6]-gingerol lessen hypoxia-induced embryotoxicities in cultured mouse whole embryos via upregulation of hypoxia-inducible factor 1 alpha and intracellular superoxide dismutases. Reproductive Toxicology 31: 513-518.
122. Zhu B, Lin Y, Zhu CF, Zhu XL, Huang CZ, et al. (2011) Emodin inhibits extracellular matrix synthesis by suppressing p38 and ERK1/2 pathways in TGF-beta 1-stimulated NRK-49F cells. Molecular Medicine Reports 4: 505-509.
123. Ha MK, Song YH, Jeong SJ, Lee HJ, Jung JH, et al. (2011) Emodin Inhibits Proinflammatory Responses and Inactivates Histone Deacetylase 1 in Hypoxic Rheumatoid Synoviocytes. Biological & Pharmaceutical Bulletin 34: 1432-1437.
124. Wang R, Wan Q, Zhang Y, Huang FF, Yu KZ, et al. (2007) Emodin suppresses interleukin-1 beta induced mesangial cells proliferation and extracellular matrix production via inhibiting P38 MAPK. Life Sciences 80: 2481-2488. (Pubitemid 46818295)
125. Wang JP, Huang HQ, Liu PQ, Tang FT, Qin J, et al. (2006) Inhibition of phosphorylation of p38 MAPK involved in the protection of nephropathy by emodin in diabetic rats. European Journal of Pharmacology 553: 297-303. (Pubitemid 44779584)
126. Fujimoto H, Satoh Y, Yamaguchi K, Yamazaki M (1998) Monoamine oxidase inhibitory constituents from Anixiella micropertusa. Chemical & Pharmaceutical Bulletin 46: 1506-1510. (Pubitemid 28531006)
127. Heyman SN, Khamaisi M, Rosen S, Rosenberger C (2008) Renal parenchymal hypoxia, hypoxia response and the progression of chronic kidney disease. American Journal of Nephrology 28: 998-1006.
128. Navab KD, Hama SY, Safarpour S, Hough GP, Vakili L, et al. (2011) Chronic Inflammatory Disorders and Accelerated Atherosclerosis: Chronic Kidney Disease. Current Pharmaceutical Design 17: 17-20.
129. Brophy D, Martin E, White N, Gehr T (2009) Blood Coagulation across the Spectrum of Chronic Kidney Disease. American Journal of Kidney Diseases 53: A30-A30.
130. Stinghen AEM, Bucharles S, Riella MC, Pecoits R (2010) Immune Mechanisms Involved in Cardiovascular Complications of Chronic Kidney Disease. Blood Purification 29: 114-120.
131. Mencher SK, Wang LG (2005) Promiscuous drugs compared to selective drugs (promiscuity can be a virtue). BMC Clin Pharmacol 5: 3.
132. Shi CS, Huang HC, Wu HL, Kuo CH, Chang BI, et al. (2007) Salvianolic acid B modulates hemostasis properties of human umbilical vein endothelial cells. Thrombosis Research 119: 769-775. (Pubitemid 46441421)
133. Abdel-Rahman E, Holley JL (2009) A Review of the Effects of Growth Hormone Changes on Symptoms of Frailty in the Elderly with Chronic Kidney Disease. Seminars in Dialysis 22: 532-538.
134. Kim SK, Jung KH, Lee BC (2009) Protective Effect of Tanshinone IIA on the Early Stage of Experimental Diabetic Nephropathy. Biological & Pharmaceutical Bulletin 32: 220-224.
135. Dubey RK, Gillespie DG, Imthurn B, Rosselli M, Jackson EK, et al. (1999) Phytoestrogens inhibit growth and MAP kinase activity in human aortic smooth muscle cells. Hypertension 33: 177-182. (Pubitemid 29065656)
136. Ko JC, Tsai MS, Kuo YH, Chiu YF, Weng SH, et al. (2011) Modulation of Rad51, ERCC1, and thymidine phosphorylase by emodin result in synergistic cytotoxic effect in combination with capecitabine. Biochemical Pharmacology 81: 680-690.
137. Fernand VE, Losso JN, Truax RE, Villar EE, Bwambok DK, et al. (2011) Rhein inhibits angiogenesis and the viability of hormone-dependent and - independent cancer cells under normoxic or hypoxic conditions in vitro. Chemico-Biological Interactions 192: 220-232.
138. Garcia-Mediavilla V, Crespo I, Collado PS, Esteller A, Sanchez-Campos S, et al. (2007) The anti-inflammatory flavones quercetin and kaempferol cause inhibition of inducible nitric oxide synthase, cyclooxygenase-2 and reactive Cprotein, and down-regulation of the nuclear factor kappaB pathway in Chang Liver cells. European Journal of Pharmacology 557: 221-229. (Pubitemid 46186282)
139. Chuang CC, Martinez K, Xie G, Kennedy A, Bumrungpert A, et al. (2010) Quercetin is equally or more effective than resveratrol in attenuating tumor necrosis factor-{alpha}-mediated inflammation and insulin resistance in primary human adipocytes. Am J Clin Nutr 92: 1511-1521.
140. Hu YB, Peng JB, Gu S, Pei JF, Zou ZM (2012) Molecular Docking in Xin-Ke- Shu Preparation's Multi-Target Effect on Coronary Heart Disease. Acta Physico-Chimica Sinica 28: 1257-1264.
141. Li S, An TY, Li J, Shen Q, Lou FC, et al. (2006) PTP1-B inhibitors from Saussrurea Lappa. Journal of Asian Natural Products Research 8: 281-286.
142. Lee W, Yoon G, Hwang YR, Kim YK, Kim SN (2012) Anti-obesity and hypolipidemic effects of Rheum undulatum in high-fat diet-fed C57BL/6 mice through protein tyrosine phosphatase 1B inhibition. Bmb Reports 45: 141-146.
143. Gonzalez-Salazar A, Molina-Jijon E, Correa F, Zarco-Marquez G, Calderon-Oliver M, et al. (2011) Curcumin Protects from Cardiac Reperfusion Damage by Attenuation of Oxidant Stress and Mitochondrial Dysfunction. Cardiovascular Toxicology 11: 357-364.
144. Hu Y, Liang H, Du Y, Zhu YL, Wang XD (2010) Curcumin Inhibits Transforming Growth Factor-beta Activity via Inhibition of Smad Signaling in HK-2 Cells. American Journal of Nephrology 31: 332-341.
145. Kong LD, Cheng CHK, Tan RX (2004) Inhibition of MAO A and B by some plant-derived alkaloids, phenols and anthraquinones. Journal of Ethnopharmacology 91: 351-355. (Pubitemid 38561134)
146. Hwang JS, Lee SA, Hong SS, Lee KS, Lee MK, et al. (2005) Monoamine oxidase inhibitory components from the roots of Sophora flavescens. Archives of Pharmacal Research 28: 190-194. (Pubitemid 43073672)
147. Tang JL, Liu BY, Ma KW (2008) Traditional Chinese medicine. Lancet 372: 1938-1940.
148. Wu LC, Lin X, Sun H (2012) Tanshinone IIA protects rabbits against LPSinduced disseminated intravascular coagulation (DIC). Acta Pharmacologica Sinica 33: 1254-1259.
149. Eybl V, Kotyzova D, Cerna P, Koutensky J (2008) Effect of melatonin, curcumin, quercetin, and resveratrol on acute ferric nitrilotriacetate (Fe-NTA)- induced renal oxidative damage in rats. Human & Experimental Toxicology 27: 347-353.
150. Lai PB, Zhang L, Yang LY (2012) Quercetin Ameliorates Diabetic Nephropathy by Reducing the Expressions of Transforming Growth Factorbeta 1 and Connective Tissue Growth Factor in Streptozotocin-Induced Diabetic Rats. Renal Failure 34: 83-87.
151. Wu XL, Liu LH, Xie HB, Liao JT, Zhou X, et al. (2012) Tanshinone IIA Prevents Uric Acid Nephropathy in Rats through NF-kappa B Inhibition. Planta Medica 78: 866-873.
152. Soetikno V, Sari FR, Veeraveedu PT, Thandavarayan RA, Harima M, et al.
153. Gao S, Liu ZP, Li H, Little PJ, Liu PQ, et al. (2012) Cardiovascular actions and therapeutic potential of tanshinone IIA. Atherosclerosis 220: 3-10.
154. Ahn YM, Kim SK, Lee SH, Ahn SY, Kang SW, et al. (2010) Renoprotective Effect of Tanshinone IIA, An Active Component of Salvia miltiorrhiza, on Rats with Chronic Kidney Disease. Phytotherapy Research 24: 1886-1892.
155. Hsieh CL, Peng CC, Chen KC, Peng RY (2013) Rutin (Quercetin Rutinoside) Induced Protein-Energy Malnutrition in Chronic Kidney Disease, but Quercetin Acted Beneficially. Journal of Agricultural and Food Chemistry 61: 7258-7267.
156. Zhao YL, Zhou GD, Yang HB, Wang JB, Shan LM, et al. (2011) Rhein protects against acetaminophen-induced hepatic and renal toxicity. Food and Chemical Toxicology 49: 1705-1710.
157. Li S (2011) Network target: a starting point for traditional Chinese medicine network pharmacology. China Journal of Chinese Materia Medica 36: 2017-2020.
158. Huang XZ, Wang J, Huang C, Chen YY, Shi GY, et al. (2008) Emodin enhances cytotoxicity of chemotherapeutic drugs in prostate cancer cells. Cancer Biology & Therapy 7: 468-475.
159. Tsukiyama F, Nakai Y, Yoshida M, Tokuhara T, Hirota K, et al. (2006) Gallate, the component of HIF-inducing catechins, inhibits HIF prolyl hydroxylase. Biochemical and Biophysical Research Communications 351: 234-239. (Pubitemid 44635431)
160. Li YS, Yang YP, Yu D, Liang QS (2009) The Effect of Tanshinone IIA upon the TGF-beta1/Smads signaling pathway in hypertrophic myocardium of hypertensive rats. Journal of Huazhong University of Science and Technology- Medical Sciences 29: 476-480.
161. Tang FT, Cao YA, Wang TQ, Wang LJ, Guo JA, et al. (2011) Tanshinone IIA attenuates atherosclerosis in ApoE(-/-) mice through down-regulation of scavenger receptor expression. European Journal of Pharmacology 650: 275-284.
162. Gong ZW, Huang C, Sheng XY, Zhang YB, Li QY, et al. (2009) The Role of Tanshinone IIA in the Treatment of Obesity through Peroxisome Proliferator- Activated Receptor gamma Antagonism. Endocrinology 150: 104-113.
163. Kuppusamy UR, Das NP (1994) Potentiation of beta-adrenoceptor agonist-mediated lipolysis by quercetin and fisetin in isolated rat adipocytes. Biochem Pharmacol 47: 521-529. (Pubitemid 24071533)
164. Xavier S, Sadanandan J, George N, Paulose CS (2012) beta(2)-Adrenoceptor and insulin receptor expression in the skeletal muscle of streptozotocin induced diabetic rats: Antagonism by vitamin D-3 and curcumin. European Journal of Pharmacology 687: 14-20.
165. Ma QL, Yang FS, Rosario ER, Ubeda OJ, Beech W, et al. (2009) beta- Amyloid Oligomers Induce Phosphorylation of Tau and Inactivation of Insulin Receptor Substrate via c-Jun N-Terminal Kinase Signaling: Suppression by Omega-3 Fatty Acids and Curcumin. Journal of Neuroscience 29: 9078-9089.